Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors

Clinical trial NCT06650163 · RECRUITING

Trial details

NCT number: NCT06650163
Sponsor: Jonsson Comprehensive Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Glioma Malignant Brain Neoplasm Meningioma Metastatic Malignant Neoplasm in the Brain

Start date: 2024-12-05
Primary completion: 2027-01-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.